TGA Approval

TRODELVY sacituzumab govitecan 180 mg powder for injection vial (353081)

ARTG ID

353081

ARTG Name

TRODELVY sacituzumab govitecan 180 mg powder for injection vial

Sponsor

Gilead Sciences Pty Ltd

ARTG Date

September 6, 2021

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

GILEAD SCIENCES PTY LIMITED

https://medical-cdn.nocode.com/drug_tga/18aca39cb8cfa68a301fb2a5273d4bbd.pdf

https://medical-cdn.nocode.com/drug_tga/faacb14b2c0a00b7fa0824679a3172b0.pdf

Ingredient Name

sacituzumab govitecan

Empowering clinical research with data-driven insights and AI-powered tools.

TRODELVY sacituzumab govitecan 180 mg powder for injection vial (353081) - TGA 批准文号 | MedPath